Markets
markets

Boeing surges on end-of-month prediction on deliveries

Boeing shares rose more than 6% in early trading after Bank of America analysts projected that the embattled jet and rocket maker would see an unexpected rise in deliveries at the end of March.

March deliveries for the Boeing 737 jet are expected to exceed February’s total and potentially match January’s levels of 40 units, the analysts wrote. There is usually an end-of-quarter deliveries push, they noted. Meanwhile, the Boeing 787, a larger plane, saw no deliveries so far this month, though five are expected.

The company’s stock has been on a rollercoaster ride in the past year or so since one of its passenger planes fell apart midair and its Starliner left astronauts stranded in space.

March deliveries for the Boeing 737 jet are expected to exceed February’s total and potentially match January’s levels of 40 units, the analysts wrote. There is usually an end-of-quarter deliveries push, they noted. Meanwhile, the Boeing 787, a larger plane, saw no deliveries so far this month, though five are expected.

The company’s stock has been on a rollercoaster ride in the past year or so since one of its passenger planes fell apart midair and its Starliner left astronauts stranded in space.

More Markets

See all Markets
markets

Citi upgrades Palantir to “buy,” citing recent conversations with CIOs

Citi analysts hit the buy button on Palantir Technologies Monday, citing a strong outlook for growth both in Palantir’s large government contracting and defense business as well as its rapidly growing commercial division, which sells software to corporations to help them better use AI technology.

“Our upgrade is premised on our view that 2026 is poised to be another year of significant positive estimate revisions, with recent CIO [Chief Information Officer] + industry conversations suggesting AI budget and use cases are accelerating in the enterprise. We also see significant tailwinds in the Government driven by accelerating defense budgets and modernization urgency.”

The bank, which had a “neutral” rating on the stock since February 2024, also cited chatter at its recent IT software conference, where participants talked up the cost savings generated by Palantir’s AI Platform software and noted that its Q4 IT survey on software budgets showed an incremental rise in budgets “especially for dedicated AI workloads and data project prioritization.”

“We expect PLTR, with its Foundry and AIP platform, to be one of the key Data Analytics/ AI vendors that could see further tailwind into numbers,” Citi analysts wrote.

Palantir is expected to report Q4 results on February 18.

But it’s an open question whether the surging growth Citi now sees for the company has already been priced in for the stock. The shares have risen close to 1,000% over the last two years, pushing standard measures of valuation to arguably lunatic levels.

markets

Chinese food delivery stocks soar as regulatory probe into price wars may save them from themselves

If there’s one thing Chinese companies are known for, it’s ruthless competition on price to make sure the nation’s products are attractive on global markets. Oftentimes, this comes with implicit or explicit state support for favored industries, which draws the ire of other countries.

Production > profitability is a pretty good shorthand for how China attempts to conquer tradable goods (see: electric vehicles). However, when it comes to consumer-oriented services, policymakers clearly don’t feel the same way.

Alibaba, Meituan, andJD.com are all soaring after the Chinese State Council’s anti-monopoly and anti-unfair competition committee said it’s investigating the food delivery sector over practices that are potentially distorting the market and weighing on brick-and-mortar firms.

These tech giants have been investing heavily in their food delivery capabilities, including via subsidies and incentives. Effectively, the market reaction here is that traders believe regulators are saving these companies from themselves.

A commentary in the state-run People’s Daily published midyear 2025, when JD.com announced plans to bolster its food delivery business, argued that there will be no “winners” in these price wars, which would lead to irrational consumption.

markets

Tempus AI rises on better-than-expected sales numbers

Cancer diagnostics company and retail shareholder favorite Tempus AI surged early Monday after issuing some fresh, though preliminary, financials ahead of an appearance at an investor conference today.

The Chicago-based company reported better-than-expected Q4 sales numbers of roughly $367 million — Wall Street had expected about $361 million — as well as a diagnostics revenue that more than doubled to $266 million. It also posted an updated corporate presentation on its website ahead of an appearance at the JPMorgan Healthcare Conference that’s expected at 4:30 p.m. ET today.

The company noted that it hasn’t completed its official full-year 2025 or Q4 financial statements yet, which it typically files in February.

Wall Street expects Tempus to lose money through 2027. But the stock has been ripping, rising 75% last year, and through Monday’s open has tacked on another 24% in 2026.

markets

Abivax rises amid report Eli Lilly is preparing a €15 billion bid

French biotech Abivax rose more than 20% in premarket trading after French outlet La Lettre reported that Eli Lilly is preparing a €15 billion bid (or roughly $17.5 billion) for the company.

Lilly has yet to submit a formal bid and is awaiting a regulatory green light, the outlet reported.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.